These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36181917)

  • 21. Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic-Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy.
    Liu H; Hu Y; Sun Y; Wan C; Zhang Z; Dai X; Lin Z; He Q; Yang Z; Huang P; Xiong Y; Cao J; Chen X; Chen Q; Lovell JF; Xu Z; Jin H; Yang K
    ACS Nano; 2019 Nov; 13(11):12638-12652. PubMed ID: 31625721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photosensitizers with multiple degradation modes for efficient and postoperatively safe photodynamic therapy.
    Li Y; Zhang P; Xie Y; Yang J; Yang Y; Shi L; Wu W; Li Z
    Biomaterials; 2023 Aug; 299():122182. PubMed ID: 37276795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineered Extracellular Vesicles Expressing Siglec-10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor-Associated Antigens for Photodynamic Immunotherapy.
    Sun Z; Sun Z; Liu J; Gao X; Jiao L; Zhao Q; Chu Y; Wang X; Deng G; Cai L
    Small; 2024 Mar; 20(12):e2307147. PubMed ID: 37941517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuning Organelle Specificity and Photodynamic Therapy Efficiency by Molecular Function Design.
    Liu Z; Zou H; Zhao Z; Zhang P; Shan GG; Kwok RTK; Lam JWY; Zheng L; Tang BZ
    ACS Nano; 2019 Oct; 13(10):11283-11293. PubMed ID: 31525947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy.
    Pham TC; Nguyen VN; Choi Y; Lee S; Yoon J
    Chem Rev; 2021 Nov; 121(21):13454-13619. PubMed ID: 34582186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
    Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
    Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-Cell-Activated Photodynamic Therapy Assisted by Cu(II)-Based Metal-Organic Framework.
    Wang Y; Wu W; Liu J; Manghnani PN; Hu F; Ma D; Teh C; Wang B; Liu B
    ACS Nano; 2019 Jun; 13(6):6879-6890. PubMed ID: 31194910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydroartemisinin prompts amplification of photodynamic therapy-induced reactive oxygen species to exhaust Na/H exchanger 1-mediated glioma cells invasion and migration.
    Hou K; Liu J; Du J; Mi S; Ma S; Ba Y; Ji H; Li B; Hu S
    J Photochem Photobiol B; 2021 Jun; 219():112192. PubMed ID: 34000476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
    Yao D; Wang Y; Bian K; Zhang B; Wang D
    Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aptamer-Targeted Photodynamic Platforms for Tumor Therapy.
    Yan J; Gao T; Lu Z; Yin J; Zhang Y; Pei R
    ACS Appl Mater Interfaces; 2021 Jun; 13(24):27749-27773. PubMed ID: 34110790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Biomimetic Aggregation-Induced Emission Photosensitizer with Antigen-Presenting and Hitchhiking Function for Lipid Droplet Targeted Photodynamic Immunotherapy.
    Xu X; Deng G; Sun Z; Luo Y; Liu J; Yu X; Zhao Y; Gong P; Liu G; Zhang P; Pan F; Cai L; Tang BZ
    Adv Mater; 2021 Aug; 33(33):e2102322. PubMed ID: 34247428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondria-Targeting and Multiresponsive Nanoplatform Based on AIEgens for Synergistic Chemo-Photodynamic Therapy and Enhanced Immunotherapy.
    Feng Q; Xu J; Zhuang C; Xiong J; Wang H; Xiao K
    Biomacromolecules; 2023 Feb; 24(2):977-990. PubMed ID: 36703538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy.
    Chen J; Tan X; Huang Y; Xu C; Zeng Z; Shan T; Guan Z; Xu X; Huang Z; Zhao C
    Biomaterials; 2022 May; 284():121513. PubMed ID: 35398586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia alleviation-triggered enhanced photodynamic therapy in combination with IDO inhibitor for preferable cancer therapy.
    Xing L; Gong JH; Wang Y; Zhu Y; Huang ZJ; Zhao J; Li F; Wang JH; Wen H; Jiang HL
    Biomaterials; 2019 Jun; 206():170-182. PubMed ID: 30939409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chondroitin sulfate-based prodrug nanoparticles enhance photodynamic immunotherapy via Golgi apparatus targeting.
    Li H; Deng C; Tan Y; Dong J; Zhao Y; Wang X; Yang X; Luo J; Gao H; Huang Y; Zhang ZR; Gong T
    Acta Biomater; 2022 Jul; 146():357-369. PubMed ID: 35577045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innovative strategies for enhanced tumor photodynamic therapy.
    Li G; Wang Q; Liu J; Wu M; Ji H; Qin Y; Zhou X; Wu L
    J Mater Chem B; 2021 Sep; 9(36):7347-7370. PubMed ID: 34382629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondria-targeted nanoplatforms for enhanced photodynamic therapy against hypoxia tumor.
    Wen J; Luo Y; Gao H; Zhang L; Wang X; Huang J; Shang T; Zhou D; Wang D; Wang Z; Li P; Wang Z
    J Nanobiotechnology; 2021 Dec; 19(1):440. PubMed ID: 34930284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggregation-Induced Emission Luminogens for Enhanced Photodynamic Therapy: From Organelle Targeting to Tumor Targeting.
    Zhou J; Qi F; Chen Y; Zhang S; Zheng X; He W; Guo Z
    Biosensors (Basel); 2022 Nov; 12(11):. PubMed ID: 36421144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.
    Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M
    J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.